Measurement of Nanoparticle Uptake by Alveolar Macrophages - Safety of Nanomaterials along Their Lifecycle - page 155

REFERENCES
Gosens, I., Post, J. A., de la Fonteyne, L. J. J. et al., 2010. Impact of agglomeration state
of nano- and sub-micron sized gold particles on pulmonary inflammation. Part Fibre
Toxicol 7:3-7.
Hinderliter, P. M., Minard, K. R., Orr, G. et al., 2010. ISDD: A computational model of particle
sedimentation, diffusion and target cell dosimetry for in vitro toxicity studies. Part Fibre
Toxicol 7:36-55.
Kroll, A., Dierker, C., Rommel, C. et al., 2011. Cytotoxicity screening of 23 engineered
nanomaterials using a test matrix of ten cell lines and three different assays. Part Fibre
Toxicol 8:9.
Lanone, S., Rogerieux, F., Geys, J. et al., 2009. Comparative toxicity of 24 manufactured
nanoparticles in human alveolar epithelial and macrophage cell lines. Part Fibre Toxicol
6:14-25.
Oberdörster, G., Ferin, J., Gelein, R. et al., 1992. Role of the alveolar macrophage in lung
injury: Studies with ultrafine particles. Environ Health Perspect 97:193-199.
Oberdörster, G., Maynard, A., Donaldson, K. et al., 2005a. Principles for characterizing the
potential human health effects from exposure to nanomaterials: Elements of a screening
strategy. Part Fibre Toxicol 2:8-42.
Oberdörster, G., Oberdörster, E., Oberdörster, J., 2005b. Nanotoxicology: An emerging disci-
pline evolving from studies of ultrafine particles. Environ Health Perspect 113:823-839.
Pauluhn, J., 2009. Pulmonary toxicity and fate of agglomerated 10 and 40 nm aluminum oxy-
hydroxides following 4-week inhalation exposure of rats: Toxic effects are determined
by agglomerated, not primary particle size. Toxicol Sci 109:152-167.
Rehn, B., Rehn, S., Bruch, J., 1999. Ein neues In-vitro-Prüfkonzept (Vektorenmodell) zum
biologischen Screening und Monitoring der Lungentoxizität von Stäuben. Gefahrstoffe-
Reinhaltung der Luft 59:181-189.
Rothen-Rütishauer, B., Mühlfeld, C., Blank, F. et al., 2007. Translocation of particles and
inflammatory responses after exposure to fine particles and nanoparticles in an epithelial
airway model. Part Fibre Toxicol 4:9-17.
Schippritt, D, Wiemann, M., Lipinski, H. G., 2010. Sedimentation of agglomerated nanopar-
ticles under cell culture conditions studied by image based analysis. Proc SPIE 7715:
77153A-77153A.
Semmler-Behnke, M., Takenaka, S., Fertsch, S. et al., 2007. Efficient elimination of inhaled
nanoparticles from the alveolar region: Evidence for interstitial uptake and subsequent
reentrainment onto airways epithelia. Environ Health Perspect 115:728-733.
Teeguarden, J. G., Hinderliter, P. M., Orr, G. et al., 2007. Particokinetics in vitro: Dosimetry
considerations for in vivo nanoparticle toxicity assessments. Toxicol Sci 95:300-312.
Wang, S. -H, Lee, C. -W., Chiou, A. et al., 2010. Size-dependent endocytosis of gold
nanoparticles studied by three-dimensional mapping of placmonic scattering images.
J Nanobiotechnol 8:33-45.
Wiemann, M., Bruch, J., 2009. Comparison of in vitro and in vivo findings. In NanoCare .
Health Related Aspects of Nanomaterials . Final Scientific Report, ed. T.A.J. Kuhlbusch,
H.F. Krug, and K. Nau. Dechema e.V., Frankfurt, Germany.
Xia, T., Li, N., Nel, A., 2009. Potential health impact of nanoparticles. Public Health
30:137-150.